Jill Werry

Jill Werry has extensive work experience in the pharmaceutical and healthcare industry. Currently, they are serving as the Sr. Director of Marketing at Neurelis, Inc. Previously, they held a similar role at Jazz Pharmaceuticals from June 2020 to November 2022.

Prior to that, Jill worked at Actelion as the Group Product Director, Franchise Marketing from October 2017 to June 2020. Jill was responsible for developing and executing marketing strategies for the franchise.

Jill also worked at Mylan as the Director of Marketing from August 2016 to January 2017. Jill led pre-launch strategy development and planning for multiple HIV products, conducting qualitative and quantitative studies to identify unmet needs.

Before Mylan, Jill was employed at Allergan as the Product Director for Botox Spasticity and Movement Disorders Marketing from September 2011 to January 2016. Jill led annual business planning and developed strategies across multiple indications.

Jill's earlier experience includes roles at Cephalon as a Sr. Product Manager from June 2010 to September 2011 and at Novartis Pharmaceuticals Corp from November 2000 to April 2010. At Novartis, they played a significant role in building the Multiple Sclerosis franchise and launching products like Extavia and Gilenya.

Their career began at CommonHealth in March 1996, where they worked as an Account Manager. Jill managed various accounts and supervised the coordination department.

Overall, Jill Werry's work experience demonstrates their expertise in marketing and strategic planning in the pharmaceutical and healthcare sectors.

Jill Werry has a Bachelor of Arts (B.A.) degree in Sociology from Shippensburg University of Pennsylvania. The start and end years of their education were not provided.